Literature DB >> 11992798

The value of laparoscopy in the management of ampullary, duodenal, and distal bile duct tumors.

Ari D Brooks1, Michael J Mallis, Murray F Brennan, Kevin C P Conlon.   

Abstract

Laparoscopy identifies radiologically occult advanced disease in patients with pancreatic adenocarcinoma. The value of laparoscopy in the management of peri-ampullary tumors was determined. One hundred forty-four patients with radiologically resectable nonpancreatic adenocarcinoma, periampullary tumors were identified from a prospective database between August 1993 and December 2000. Criteria for laparoscopic unresectability included histologically proved peritoneal or hepatic metastases, distant nodal involvement, arterial involvement, and local extension outside the resection field. Median age at operation was 70 years (range 31 to 87 years) and 56% of the patients were men. An adequate laparoscopy was performed in 134 cases (93%). Laparoscopy identified 13 patients (10%) with unresectable disease. Of 121 patients with laparoscopic resectable disease, 111 (92%) went on to subsequent resection; CT correctly predicted resectability in 82%. Laparoscopy spared 36% of unresectable patients a nontherapeutic laparotomy. Patients with resectable disease were treated by pancreaticoduodenectomy (n = 91, 76%), ampullectomy (n = 12, 10%), duodenal resection (n = 10, 9%), or bile duct excision (n = 6, 5%). The addition of diagnostic laparoscopy to dynamic CT scanning in this selected patient population identifies an additional 10% of patients with unresectable disease. We believe that laparoscopy should be used in a selective manner for preoperative staging of patients suspected of having nonpancreatic periampullary tumors.

Entities:  

Mesh:

Year:  2002        PMID: 11992798     DOI: 10.1016/s1091-255x(01)00021-x

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  22 in total

1.  TNM staging and assessment of resectability of pancreatic cancer by laparoscopic ultrasonography.

Authors:  J Durup Scheel-Hincke; M B Mortensen; N Qvist; C P Hovendal
Journal:  Surg Endosc       Date:  1999-10       Impact factor: 4.584

2.  Laparoscopy for pancreatic cancer: does it benefit the patient?

Authors:  A Cuschieri
Journal:  Eur J Surg Oncol       Date:  1988-02       Impact factor: 4.424

3.  Experience with staging laparoscopy in pancreatic malignancy.

Authors:  K R Reddy; J Levi; A Livingstone; L Jeffers; E Molina; S Kligerman; D Bernstein; V P Kodali; E R Schiff
Journal:  Gastrointest Endosc       Date:  1999-04       Impact factor: 9.427

4.  Local extension of pancreatic carcinoma: assessment with thin-section helical CT versus with breath-hold fast MR imaging--ROC analysis.

Authors:  T Nishiharu; Y Yamashita; Y Abe; K Mitsuzaki; T Tsuchigame; Y Nakayama; M Takahashi
Journal:  Radiology       Date:  1999-08       Impact factor: 11.105

5.  Ultrafast magnetic resonance imaging improves the staging of pancreatic tumors.

Authors:  M Trede; B Rumstadt; K Wendl; J Gaa; K Tesdal; K J Lehmann; H J Meier-Willersen; P Pescatore; J Schmoll
Journal:  Ann Surg       Date:  1997-10       Impact factor: 12.969

6.  Is CT angiography sufficient for prediction of resectability of periampullary neoplasms?

Authors:  P F Saldinger; M Reilly; K Reynolds; V Raptopoulos; R Chuttani; M L Steer; J B Matthews
Journal:  J Gastrointest Surg       Date:  2000 May-Jun       Impact factor: 3.452

7.  The use of diagnostic laparoscopy supported by laparoscopic ultrasonography in the assessment of pancreatic cancer.

Authors:  J M Catheline; R Turner; N Rizk; C Barrat; G Champault
Journal:  Surg Endosc       Date:  1999-03       Impact factor: 4.584

8.  The role of laparoscopy in the management of suspected pancreatic and periampullary malignancies.

Authors:  M D Holzman; K L Reintgen; D S Tyler; T N Pappas
Journal:  J Gastrointest Surg       Date:  1997 May-Jun       Impact factor: 3.452

9.  Laparoscopy and laparoscopic ultrasound for staging of upper gastrointestinal tumours.

Authors:  M Hünerbein; B Rau; P M Schlag
Journal:  Eur J Surg Oncol       Date:  1995-02       Impact factor: 4.424

Review 10.  Laparoscopic evaluation in pancreatic cancer.

Authors:  N B Merchant; K C Conlon
Journal:  Semin Surg Oncol       Date:  1998 Oct-Nov
View more
  6 in total

1.  The utility of laparoscopic assessment in the preoperative staging of suspected hilar cholangiocarcinoma.

Authors:  Saxon Connor; Emma Barron; Stephen J Wigmore; Krishnakumar K Madhavan; Rowan W Parks; O James Garden
Journal:  J Gastrointest Surg       Date:  2005-04       Impact factor: 3.452

Review 2.  Review of the investigation and surgical management of resectable ampullary adenocarcinoma.

Authors:  James Askew; Saxon Connor
Journal:  HPB (Oxford)       Date:  2013-01-10       Impact factor: 3.647

Review 3.  Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer.

Authors:  Victoria B Allen; Kurinchi Selvan Gurusamy; Yemisi Takwoingi; Amun Kalia; Brian R Davidson
Journal:  Cochrane Database Syst Rev       Date:  2016-07-06

4.  Cost-effectiveness of diagnostic laparoscopy for assessing resectability in pancreatic and periampullary cancer.

Authors:  Stephen Morris; Kurinchi S Gurusamy; Jessica Sheringham; Brian R Davidson
Journal:  BMC Gastroenterol       Date:  2015-04-02       Impact factor: 3.067

5.  Routine contrast-enhanced CT is insufficient for TNM-staging of duodenal adenocarcinoma.

Authors:  G Litjens; C J H M van Laarhoven; M Prokop; E J M van Geenen; J J Hermans
Journal:  Abdom Radiol (NY)       Date:  2022-07-21

6.  A phase I pilot study of autologous heat shock protein vaccine HSPPC-96 in patients with resected pancreatic adenocarcinoma.

Authors:  Robert G Maki; Philip O Livingston; Jonathan J Lewis; Sylvia Janetzki; David Klimstra; Diann Desantis; Pramod K Srivastava; Murray F Brennan
Journal:  Dig Dis Sci       Date:  2007-04-10       Impact factor: 3.487

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.